# Clinical Trial of Bile Etiology ,Proteomics and Metabonomics of Malignant Biliary Obstruction

> **NCT01073514** · — · UNKNOWN · sponsor: **Tianjin Medical University Cancer Institute and Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Malignant Biliary Obstruction

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01073514
- **Lead sponsor:** Tianjin Medical University Cancer Institute and Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-12
- **Primary completion:** 2016-11
- **Final completion:** 2016-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2015-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01073514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01073514, "Clinical Trial of Bile Etiology ,Proteomics and Metabonomics of Malignant Biliary Obstruction". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01073514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*